Treating elevated blood pressure during hospital stays to see if it changes outcomes
Official title: Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes: the ACT-BP Pilot
Run by The Cleveland Clinic · NCT07208669 · Data updated 2026-11-12
We are testing whether changing how hospitals respond to briefly high blood pressure in adults on general medical units reduces unnecessary increases in blood-pressure medicines and improves patient outcomes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 4 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 2 sites (Cleveland, Ohio and 1 other locations) |
| Status | Recruiting |
| Started | November 11, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | July 31, 2027 |
| Registry record updated | January 8, 2026 |
| Trial ID | NCT07208669 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with hypertension admitted to non-ICU general medical units who have asymptomatic elevated blood pressure readings and do not meet exclusion criteria are the intended candidates.
✕Probably not a fit
Patients with hypertensive emergencies or active cardiovascular events, those on dialysis or with end-stage renal disease, pregnant or postpartum women, very short or prolonged hospital stays, ICU transfers, or those whose systolic BP stays below 160 mmHg are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This unit-level intervention called ACT-BP removes standing orders that prompt automatic physician notification for elevated blood pressures, provides education about potential harms of treating asymptomatic inpatient BP elevations, and suggests alternatives such as more frequent monitoring and nonpharmacologic measures. The intervention is implemented at the hospital-unit level on general medical wards and outcomes include the rate of antihypertensive medication intensification and downstream patient events. The study is designed to generate the key feasibility and outcome data needed to plan a larger cluster-randomized trial that will determine whether inpatient intensification affects readmissions and adverse events. Enrollment excludes patients with hypertensive emergencies, active cardiovascular events, dialysis-dependent renal failure, pregnancy, very short or very long stays, ICU transfers, or systolic BP that remains below 160 mmHg during hospitalization.
Why it matters
Potential benefit: If successful, the approach could reduce unnecessary increases in blood-pressure medications and lower related harms such as readmissions and adverse events.
How similar studies have gone: Observational studies have suggested potential harm from inpatient antihypertensive medication intensification, but randomized evidence is lacking and unit-level interventions like ACT-BP are relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * At the unit level: Medical units that do not typically care for patients requiring step-down care. Exclusion Criteria: 1. Patients less than 18 2. Patients experiencing hypertensive emergencies or cardiac symptoms 3. Patients with active cardiovascular events, such as * Stroke * Non-ST-elevation * Myocardial infarction * End-stage renal disease * Patients on dialysis * Those with acute decompensated heart failure 3\. Patients on the unit for more than 10 days 4\. Patients transferred in after being in the intensive care unit (ICU) 5\. Pregnant and post-partum women 6\. Patients discharged within 24 hours of admission 7\. Patients whose systolic BP remains below 160 mmHg during hospitalization.
Where it's running
-
Cleveland Clinic Main Campus
Cleveland, Ohio, United States Recruiting -
Cleveland Clinic Hillcrest
Mayfield Heights, Ohio, United States Recruiting
Study contacts
- Principal investigator: Elizabeth Pfoh, PhD, MPH — The Cleveland Clinic
- Study coordinator: Elizabeth Pfoh, PhD, MPH
- Email: pfohe@ccf.org
- Phone: 12162963034
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartphone app to help follow the 2024 KDIGO chronic kidney disease guidelines
This project will test whether a smartphone app helps young adults (ages 16–29) with chronic kidney disease follow the 2024 KDIGO guideline recommendations.
-
Prilocaine versus lidocaine for sphenopalatine ganglion block during endoscopic pituitary surgery
This test sees if using prilocaine instead of lidocaine for a sphenopalatine ganglion block helps keep blood pressure steadier and reduces pain for adults aged 21–45 having endoscopic removal of a pituitary adenoma.
-
Can switching to a prebiotic soda improve blood sugar in adults who regularly drink soda
This study tests whether replacing usual non-diet soda with OLIPOP prebiotic soda for 8 weeks can improve blood sugar control in adults with glucose dysregulation who regularly drink soda.
-
Effects of Cool Roofs on Health and Indoor Environments
This study is testing if special cool roofs that reflect sunlight can help people living in hot urban areas feel better and stay healthier by reducing heat exposure.
-
SugarLock peanut skin extract before meals to see if it helps post-meal blood sugar in healthy adults
This study tests whether taking SugarLock peanut skin extract (and white kidney bean extract) before a meal can blunt or delay rises in blood glucose in healthy adults.
-
Overnight Temperature Regulation to Test Gut Health, Inflammation, and Circadian Rhythms
This study tests whether two weeks of using the Eight Sleep Pod at night can improve gut bacteria balance, lower inflammation, and strengthen daily temperature and blood pressure rhythms in postmenopausal women and age-matched men with poor sleep.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.